News & Perspective

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Jul 17, 2017

Jul 17, 2017

News Scan for Jul 17, 2017

Cyclospora in Texas
Non-prudent abx use in Europe
MERS super spreader
Smallpox vaccine deal

Mar 16, 2017

Mar 16, 2017

News Scan for Mar 16, 2017

Animal antibiotic use
E Coli in Oregon, Canada
Zika CNS birth defects
H5N8 in Europe
Cholera vaccine drive

Mar 08, 2013

Mar 08, 2013

US flu activity almost back to baseline

(CIDRAP News) – Influenza activity in the United States continued to tumble last week, with one key marker—clinic visits for flulike illness—nearly approaching the national baseline, the US Centers for Disease Control and Prevention (CDC) said today.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Feb 03, 2012

Feb 03, 2012

Flu continues late-season Northern Hemisphere push

(CIDRAP News) – Flu activity in many Northern Hemisphere countries continued its late-season rise last week, with areas such as the United States, Canada, and Europe reporting steady increases.

Though flu activity overall is low, notable increases are occurring in North America, western Europe, and northern China, the World Health Organization (WHO) said today.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»